← Insider buys
ALRN

Aileron Therapeutics, Inc.

Novartis Bioventures Ltd sold $47K of Aileron Therapeutics, Inc.

10% owner

Sold$46,892
$2.30Price
20,388Shares
−1%Stake

What ALRN did after the filing

Prices for ALRN after this filing aren't in yet.

Traded Mon, Aug 20. Filed Wed, Aug 22. Not investment advice.